Industry Updates
Press Releases
DrFirst and GoHipo Partner to Use Telehealth to Fight High Relapse Rates After Substance Abuse Treatment
DrFirst and GoHipo are collaborating to keep patients connected with their treatment centers’ care teams using a mobile app for secure messaging and telehealth services.
DrFirst...
Press Releases
DataRobot and InterSystems Partner to Accelerate Adoption of AI in Healthcare
DataRobot, the leader in enterprise AI, and InterSystems, a global leader in information technology platforms for health, business, and government applications, announced a partnership designed...
Press Releases
LivaNova VNS Therapy System, Symmetry, Granted CE Mark for Difficult-to-Treat Depression
LivaNova PLC, a market-leading medical technology and innovation company, announced its Vagus Nerve Stimulation Therapy® (VNS Therapy) System, Symmetry™, earned CE Mark approval for Difficult-to-Treat...
Press Releases
AI-Pathway Companion Prostate Cancer from Siemens Healthineers approved for use in Europe as medical device
AI-Pathway Companion Prostate Cancer, a digital companion from Siemens Healthineers to support clinical decision-making, has recently received the CE mark for use in the clinical...
Press Releases
Nexelis to Acquire Specialty Immunogenicity and Immune-Oncology Testing Laboratory ImmunXperts
Nexelis, a portfolio company of Ampersand Capital Partners, and a leading provider of assay development and advanced laboratory testing is pleased to announce the signing...
Press Releases
American Oncology Network Continues Strategic Relationship with AmerisourceBergen
global healthcare solutions leader AmerisourceBergen announced that it is continuing its strategic relationship with the American Oncology Network, LLC (AON), a high-growth medical oncology provider...
Press Releases
V-Wave Receives CE Mark for the Ventura Interatrial Shunt System
CE Mark for the Ventura™ Interatrial Shunt System is a significant milestone for V-Wave, as it recognizes that this therapeutic product conforms to the standards...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
